58 results
Page 2 of 3
6-K
EX-99.1
ibzpy ixcxquj51nsr
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.1
az1 3w4xj6kx30gq
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.1
ble37qx5
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
EX-99.1
upod86v3b61cz
13 May 22
Condensed consolidated interim financial statements
5:10pm
20-F
EX-4.14
a6mpbxj6 fqadt
31 Mar 22
Annual report (foreign)
8:09am
20-F
dap6ifdel
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.2
0014to34t42
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.2
lsqhrh
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm
6-K
EX-99.1
x13k3a0a
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
EX-99.2
km0 cy4df5ete3qh4tvg
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
EX-99.1
pgbanw dj
27 Jul 21
Appoints Anthony Durkacz as Interim Chief Executive Officer and Reinstates Zeeshan Saeed as President
9:24am
F-X
rnmfmxx291aepj
2 Apr 21
Appointment of agent for service of process by issuers registering securities
12:59pm
F-10
vxb3nusd8rhkth9j2r52
2 Apr 21
Registration of securities (Canada)
12:49pm
40-F
tmq gx2ecja5eqav
17 Mar 21
Annual report (Canada)
12:00am
40-F
EX-99.1
rg79 my5p
17 Mar 21
Annual report (Canada)
12:00am
6-K
EX-99.1
nsooiseazfp8kuok7go
11 Feb 21
Current report (foreign)
9:08am
SUPPL
tu1k zthw
11 Feb 21
Supplemental materials (foreign)
8:32am
6-K
EX-99.2
caqxc2ro0qcb5n pctaf
16 Oct 20
FSD Pharma Inc. Announces US$9.5 Million Registered Direct Offering
5:21pm
6-K
EX-99.3
qcn kdskieyama7ipmm8
16 Oct 20
FSD Pharma Inc. Announces US$9.5 Million Registered Direct Offering
5:21pm
SUPPL
41o d4grif6rvvzzdpnu
16 Oct 20
Supplemental materials (foreign)
5:19pm